Literature DB >> 24034905

Worse limb prognosis for indirect versus direct endovascular revascularization only in patients with critical limb ischemia complicated with wound infection and diabetes mellitus.

O Iida1, M Takahara, Y Soga, Y Yamauchi, K Hirano, J Tazaki, T Yamaoka, N Suematsu, K Suzuki, Y Shintani, Y Miyashita, M Uematsu.   

Abstract

OBJECTIVES: To investigate factors in patients with critical limb ischemia (CLI) and isolated infrapopliteal lesions that adversely affect outcomes of endovascular therapy (EVT) with or without angiosome-oriented revascularization.
METHODS: This was a retrospective multicenter study. We used a database of 718 consecutive CLI patients (70 ± 11 years, 75% diabetics, 68% on hemodialysis, 24% Rutherford class 6) with ischemic tissue loss due to isolated infrapopliteal lesions undergoing primary EVT. Primary outcome was MALE (major adverse limb event). Association between indirect EVT (recanalization of a non-angiosome-based artery) and outcome was assessed by Cox proportional hazard regression model.
RESULTS: C-reactive protein (CRP) level was >3 mg/dL in 32% of cases. Indirect EVT (in 307 CLI patients, 43%), was associated with MALE (p = .04, hazard ratio [95% confidence interval] 1.25 [1.01, 1.55]), and interacted with CRP >3 mg/dL (p < .004) but not with other baseline characteristics. Indirect EVT with CRP >3 mg/dL had higher MALE risk (HR 2.08), and interacted with diabetes mellitus (DM) presence. Indirect EVT with CRP >3 mg/dL and DM had higher MALE risk (HR 2.17).
CONCLUSION: Limb prognosis was equivalent for direct and indirect endovascular revascularization except in the presence of both diabetes and wound infection, when indirect revascularization has a poorer outcome.
Copyright © 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiosome; Critical limb ischemia; Endovascular therapy

Mesh:

Substances:

Year:  2013        PMID: 24034905     DOI: 10.1016/j.ejvs.2013.08.002

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

Review 1.  Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Authors:  Ehrin J Armstrong; Kalkidan Bishu; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

2.  Early-phase wound healing and long-term outcomes of a selective endovascular-first approach for treating Rutherford 5 critical limb ischemia with infrainguinal lesions.

Authors:  Kentaro Inoue; Toshihiro Onohara; Keita Mikasa; Tadashi Furuyama
Journal:  Surg Today       Date:  2016-04-18       Impact factor: 2.549

3.  The role of foot collateral vessels on angiosome-oriented revascularization.

Authors:  César Varela; Francisco Acín; Joaquin De Haro; Ignacio Michel
Journal:  Ann Transl Med       Date:  2017-11

Review 4.  The comparative efficacy of angiosome-directed and indirect revascularisation strategies to aid healing of chronic foot wounds in patients with co-morbid diabetes mellitus and critical limb ischaemia: a literature review.

Authors:  Benedictine Y C Khor; Pamela Price
Journal:  J Foot Ankle Res       Date:  2017-06-28       Impact factor: 2.303

5.  Infrapopliteal angioplasty using a combined angiosomal reperfusion strategy.

Authors:  G K Ambler; A L Stimpson; B G Wardle; D C Bosanquet; U K Hanif; S Germain; C Chick; N Goyal; C P Twine
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

6.  Is Angiosome-Guided Endovascular Therapy Worthwhile?

Authors:  Yosuke Hata; Osamu Iida; Toshiaki Mano
Journal:  Ann Vasc Dis       Date:  2019-09-25

7.  Successful limb salvage by endovascular treatment for critical limb ischemia subsequent to acute limb ischemia.

Authors:  Tetsuya Nomura; Satoshi Tasaka; Kenshi Ono; Yu Sakaue; Naotoshi Wada; Natsuya Keira; Tetsuya Tatsumi
Journal:  Oxf Med Case Reports       Date:  2019-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.